| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.5M | -3.2% |
| R&D Expense | $3.5M | -13.9% |
| SG&A Expense | $19.4M | +6.5% |
| Operating Income | -$10.6M | +23.2% |
| Pre-tax Income | -$9.3M | +32.1% |
| Income Tax | -$214K | -12.6% |
| Net Income | -$9.1M | +32.6% |
| EPS (Basic) | -$3.83 | -1220.7% |
| EPS (Diluted) | -$3.83 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | -66.9% |
| Short-term Investments | $5.7M | — |
| Accounts Receivable | $8.7M | +44.5% |
| Inventory | $14.0M | +16.7% |
| Current Assets | $38.5M | -14.3% |
| Total Assets | $45.0M | -13.1% |
| Current Liabilities | $6.7M | +7.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.7M | -5.7% |
| Capital Expenditures | $698K | +49.8% |
| Investing Cash Flow | -$6.7M | -1337.8% |
| Financing Cash Flow | -$607K | +36.6% |
| Free Cash Flow | -$10.4M | -7.8% |
| +34.1% |
| Total Liabilities |
| $8.0M |
| -1.6% |
| Stockholders' Equity | $37.0M | -15.3% |